Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Pharmaceuticals 2014, 7(7), 754-764; doi:10.3390/ph7070754
Article

Correlation between the Serum Pepsinogen I Level and the Symptom Degree in Proton Pump Inhibitor-Users Administered with a Probiotic

1
, 2
, 3
, 1
, 1
, 1
, 1
, 1
 and 4,*
Received: 15 April 2014; in revised form: 10 June 2014 / Accepted: 11 June 2014 / Published: 25 June 2014
(This article belongs to the Special Issue Probiotics and Prebiotics Update)
View Full-Text   |   Download PDF [751 KB, uploaded 25 June 2014]
Abstract: In patients with functional upper gastrointestinal disorders such as gastroesophageal reflux disease and functional dyspepsia, the presence of symptoms is thought to occur in the absence of any organic diseases and the mechanisms behind this remain unclear. We therefore examined the relationship between stomach-related biomarker levels and symptoms. Twenty-four outpatients who had taken proton-pump inhibitors every day were enrolled in this study. The subjects consumed yogurt containing 109 colony-forming units of Lactobacillus gasseri OLL2716 (LG21) every day for three months. They underwent four clinical examinations in total. Each examination consisted of answering a questionnaire with a frequency scale for the symptoms of GERD (FSSG), and included measurements of the serum gastrin, ghrelin, and pepsinogens I and II levels. As a result, the FSSG score and the PGI value showed a decrease and an increase, respectively, after LG21 treatment when analyzed without age adjustment. A multiple regression analysis with additional adjustments for gender and age revealed a strong association between the PGI value and the FSSG symptom scores. Therefore either the PGI level itself or the factors regulating the PGI level might be involved in the etiology of these symptoms.
Keywords: correlation; symptoms; PGI; PPI; LG21 correlation; symptoms; PGI; PPI; LG21
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Igarashi, M.; Nagano, J.; Tsuda, A.; Suzuki, T.; Koike, J.; Uchida, T.; Matsushima, M.; Mine, T.; Koga, Y. Correlation between the Serum Pepsinogen I Level and the Symptom Degree in Proton Pump Inhibitor-Users Administered with a Probiotic. Pharmaceuticals 2014, 7, 754-764.

AMA Style

Igarashi M, Nagano J, Tsuda A, Suzuki T, Koike J, Uchida T, Matsushima M, Mine T, Koga Y. Correlation between the Serum Pepsinogen I Level and the Symptom Degree in Proton Pump Inhibitor-Users Administered with a Probiotic. Pharmaceuticals. 2014; 7(7):754-764.

Chicago/Turabian Style

Igarashi, Muneki; Nagano, Jun; Tsuda, Ayumi; Suzuki, Takayoshi; Koike, Jun; Uchida, Tetsufumi; Matsushima, Masashi; Mine, Tetsuya; Koga, Yasuhiro. 2014. "Correlation between the Serum Pepsinogen I Level and the Symptom Degree in Proton Pump Inhibitor-Users Administered with a Probiotic." Pharmaceuticals 7, no. 7: 754-764.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert